APPLICATION
ANDA085248
TYPE
ANDA
LATEST ACTION
1987-09-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
TRICHLORMETHIAZIDE W/ RESERPINEDiscontinued
RESERPINE 0.1MG, TRICHLORMETHIAZIDE 4MG · TABLET · ORAL
Approval history
1987-09-30Manufacturing (CMC) · Supplement 19AP
1983-04-13Manufacturing (CMC) · Supplement 15AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.